Table 2.
Study | Participants | Intervention | Control treatment | Length of follow-up | Outcomes |
---|---|---|---|---|---|
Biological agents vs. epidural steroid injection | |||||
Becker et al. [19] Germany, RCT | 84 patients with nerve root pain confirmed by imaging for at least 6 weeks; Mean age 54 years; 62 % men | Epidural injection of autologous conditioned serum (Group 1) | Epidural injection of steroid triamcinolone 5 mg or 10 mg + local anaesthetic 1 ml (Groups 2 and 3) | 22 weeks | Overall pain intensity (VAS)a; Oswestry Disability Index, adverse effects [Results from groups 2 & 3 combined for the forest plot] |
Cohen et al. [26] USA, Germany, RCT | 84 patients with nerve root pain confirmed by imaging; mean duration 2.7 months; mean age 42 years; 70 % men | Transforaminal epidural injection etanercept 4 mg | Transforaminal epidural injection of steroid methyl prednisolone 60 mg + local anaesthetic 0.5 ml | 6 months (large proportion left study after 1 month)b | Global perceived effect; back and leg pain intensity (NRS); Oswestry Disability Index; reduction in analgesic consumption |
Biological agents vs. intravenous steroid | |||||
Genevay et al. [29] Switzerland, HCS | 20 patients with nerve root pain confirmed by imaging; mean duration 3.2 weeks; Mean age 47 years; 50 % men | Subcutaneous injection of etanercept 25 mg (anti-TNF alpha) ×3 | Intravenous injection of methylprednisolone 250 mg ×3 | 6 weeks | Numbers with a good clinical result (leg pain VAS < 30 or Oswestry Disability Index < 20); back and leg pain intensity (VAS); Oswestry Disability Index; Roland-Morris Questionnaire; number of discectomies |
HCS historical cohort study, RCT randomised controlled trial, TNF tumour necrosis factor, VAS visual analogue scale
aResults extracted from graphs
bAfter 1 month participants who received no benefit exited the study to pursue other treatments